|
|
Volumn 31, Issue 8, 2013, Pages 697-703
|
|
Erratum: Public Biotech 2012 - The numbers (Nature Biotechnology (2013) 31 (697-703) DOI:10.1038/nbt.2653);Public biotech 2012 - The numbers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
BEVACIZUMAB;
DARATUMUMAB;
ECULIZUMAB;
ETANERCEPT;
INFLIXIMAB;
RANIBIZUMAB;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
ROLAPITANT;
TRASTUZUMAB;
ANCA ASSOCIATED VASCULITIS;
ANKYLOSING SPONDYLITIS;
ARTICLE;
ASTHMA;
BEHCET DISEASE;
BREAST CANCER;
CANCER PATIENT;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
CHRONIC LYMPHATIC LEUKEMIA;
COLORECTAL CANCER;
CROHN DISEASE;
DECISION MAKING;
DIABETIC MACULAR EDEMA;
DIABETIC PATIENT;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
GLIOBLASTOMA;
GLYCEMIC CONTROL;
HEALTH CARE POLICY;
HEPATITIS B;
HEPATITIS C;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
JAPAN;
JUVENILE RHEUMATOID ARTHRITIS;
KIDNEY CANCER;
LARGE CELL LYMPHOMA;
LIVER FIBROSIS;
LUNG NON SMALL CELL CANCER;
LYMPHOCYTOMA;
MONEY;
MULTIPLE MYELOMA;
MULTIPLE SCLEROSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHODGKIN LYMPHOMA;
ORGANIZATION AND MANAGEMENT;
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
REIMBURSEMENT;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA VEIN OCCLUSION;
SOLID TUMOR;
STOMACH CANCER;
SYSTEMS BIOLOGY;
THYROID CANCER;
ULCERATIVE COLITIS;
UNITED STATES;
UREMIA;
BIOTECHNOLOGY;
DRUG INDUSTRY;
HUMANS;
PUBLIC SECTOR;
|
|
EID: 84883765644
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1213-1148a Document Type: Erratum |
|
Times cited : (25)
|
|
References (0)
|
